Company: PHAT
Filing Date: 2025-06-06
Form Type: 8-K
Source: 0001193125-25-137094
Chunk: 0

Company: Phathom Pharmaceuticals, Inc.
Filing Date: 2025-06-06
Form: 8-K
Item: Item 7.01
Chunk 0
---
Item 7.01 Regulation FD Disclosure.

On June 6, 2025, Phathom Pharmaceuticals, Inc. (“ Phathom” or the “ Company”), announced that the U. S. Food and Drug Administration (“ FDA”) approved the Company’s Citizen Petition filed on December 11, 2024 (the “ Citizen Petition”). A copy of the FDA’s letter approving the Citizen Petition is attached hereto as Exhibit 99.1 and is incorporated herein by reference. The FDA letter can also be found on the FDA’s website here: https://www. regulations. gov/document/FDA-2024-P-5703-0013.

The information in this Item 7.01, including the exhibits hereto, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the limitations of that section. The information contained herein and in the accompanying exhibit shall not be incorporated by reference into any filing with the U. S. Securities and Exchange Commission made by the Company, whether made before, on or after the date hereof, regardless of any general incorporation language in such filing, except as shall be expressly set forth by specific reference in such filing.